These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6992786)

  • 1. Mutagenic potential of allyl and allylic compounds. Structure-activity relationship as determined by alkylating and direct in vitro mutagenic properties.
    Eder E; Neudecker T; Lutz D; Henschler D
    Biochem Pharmacol; 1980 Apr; 29(7):993-8. PubMed ID: 6992786
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms.
    Eder E; Henschler D; Neudecker T
    Xenobiotica; 1982 Dec; 12(12):831-48. PubMed ID: 6763406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship in halogen and alkyl substituted allyl and allylic compounds: correlation of alkylating and mutagenic properties.
    Neudecker T; Lutz D; Eder E; Henschler D
    Biochem Pharmacol; 1980 Oct; 29(19):2611-7. PubMed ID: 7000076
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatographic and mutagenic analyses of 1,2-dichloropropane and 1,3-dichloropropylene and their degradation products.
    Connors TF; Stuart JD; Cope JB
    Bull Environ Contam Toxicol; 1990 Feb; 44(2):288-93. PubMed ID: 2182142
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation.
    Eder E; Neudecker T; Lutz D; Henschler D
    Chem Biol Interact; 1982 Feb; 38(3):303-15. PubMed ID: 7037213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of alpha, beta-unsaturated carbonylic compounds.
    Henschler D; Eder E
    IARC Sci Publ; 1986; (70):197-205. PubMed ID: 3539786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A straight correlation between mutagenic activity and beta-galactosidase activity induced by monofunctional alkylating agents.
    Ohtsuka M; Maekawa K
    Mutat Res; 1992 Sep; 283(1):83-6. PubMed ID: 1380669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on the mutagenic effectiveness of vinyl chloride metabolites.
    Hussain S; Osterman-Golkar S
    Chem Biol Interact; 1976 Mar; 12(3-4):265-7. PubMed ID: 767011
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic activity of allyl chloride.
    McCoy EC; Burrows L; Rosenkranz HS
    Mutat Res; 1978 Mar; 57(1):11-5. PubMed ID: 347285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical structure-activity study of mutagenic allyl chlorides.
    Boerth DW; Eder E; Rasul G; Morais J
    Chem Res Toxicol; 1991; 4(3):368-72. PubMed ID: 1912322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
    Creech HJ; Preston RK; Peck RM; O'Connell AP
    J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prophage induction and mutagenicity in Ames tester strains by alkylating agents.
    Wheeler L; Halula M; DeMeo M
    Proc West Pharmacol Soc; 1979; 22():261-4. PubMed ID: 390539
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of biotransformation in the genotoxicity of allylic compounds.
    Eder E; Dornbusch K; Fischer G
    Arch Toxicol; 1987; 60(1-3):182-6. PubMed ID: 3619639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2-Dibromo compounds. Their mutagenicity in Salmonella strains differing in glutathione content and their alkylating potential.
    Zoetemelk CE; Mohn GR; van der Gen A; Breimer DD
    Biochem Pharmacol; 1987 Jun; 36(11):1829-35. PubMed ID: 3555505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airborne mutagens bioassayed in Salmonella typhimurium.
    Talcott R; Wei E
    J Natl Cancer Inst; 1977 Feb; 58(2):449-51. PubMed ID: 319246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity and metabolism of the source-water contaminant 1,1-dichloropropene: activation by GSTT1-1 and structure-activity considerations.
    Granville CA; Ross MK; Tornero-Velez R; Hanley NM; Grindstaff RD; Gold A; Richard AM; Funasaka K; Tennant AH; Kligerman AD; Evans MV; DeMarini DM
    Mutat Res; 2005 May; 572(1-2):98-112. PubMed ID: 15790493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.